Valproate-induced hyperacute hyperammonemic coma in a patient with hypocarnitinemia
Related Experiment Video
Updated: Jun 15, 2026

Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats
Published on: November 8, 2018
Aijaz Sofi1, Nabeel A Herial, Imran I Ali
11Department of Internal Medicine; and 2Department of Neurology, University of Toledo College of Medicine, Toledo, OH.
Abstract:
Valproate-associated hyperammonemic coma in adults is a rare complication of valproate therapy and has been previously reported to occur in few days to years after initiation of therapy. We present a case of hyperammonemic coma induced within hours of initiating valproate therapy in a patient with plasma carnitine deficiency.
Related Concept Videos
Hepatic Encephalopathy
Inborn Errors of Metabolism
Overview of Protein Metabolism
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Pharmaceutical Poisoning: Treatment Strategies
Urea Cycle
